Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00005867 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: CHOP regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: mitoxantrone hydrochloride
DRUG: prednisolone
DRUG: vincristine sulfate

Sponsor

Lymphoma Trials Office